Did you know that as an IBD patient, you can have an input into IBD research studies? It’s true – if you are a member of IBD Partners, you can propose a question about your disease and researchers can then turn it into a scientific study that can have a direct impact on your care in the...

Did you know that perianal Crohn’s disease is both commonly diagnosed and a marker of more severe disease? Research estimates the incidence of perianal Crohn’s ranges from 17-43% of Crohn’s cases. For many of these patients, perianal disease comes with a host of complications, including...

Noah was only 1.5 years old when he first began exhibiting symptoms of IBD. His original doctor brushed it off as acid reflux. By the age of 2, Noah was hospitalized as failure to thrive. A new set of doctors began to track his symptoms and use pill cam endoscopy to track an area of con...

Did you know that the Crohn’s & Colitis Foundation is the largest patient organization dedicated to accelerating research toward cures for Crohn’s disease and ulcerative colitis? The Foundation funds and supports tens of millions of dollars of IBD research every year. But why is res...

Imagine if there was a test that could predict if you’d develop severe Crohn’s disease or ulcerative colitis at the time of diagnosis. PredictImmune, a biotech spinout company from Cambridge University in the United Kingdom, is working to develop just that with its PredictSure IBD™ test...

If you’ve been following the Crohn’s & Colitis Foundation, you know they've been busy making innovative changes to their research approach. They have been working to improve the way IBD clinical care is delivered through IBD Qorus, which is designed to bring patients and providers f...

Amy and Parsa are IBD patients, students at the University of California, Los Angeles (UCLA), and members of the Foundation’s National Council of College Leaders (NCCL). Their experiences living with IBD has guided their academic and career interests and led both to volunteer in an IBD ...

In July, the U.S. Food & Drug Administration (FDA) made two announcements regarding IBD treatments: New HUMIRA® biosimilar approved for ulcerative colitis and adult Crohn’s disease patients The FDA announced the approval of HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMI...

Acknowledgement: This article is a summary of “Acupuncture in Inflammatory Bowel Disease” recently published in Inflammatory Bowel Diseases by Gengqing Song, MD, Claudio Fiocchi, PM, and Jean-Paul Achkar, MD. The article was written by Nataly Shtraizent, PhD. In the past deca...

Benefits of self-management interventions for young patients with IBD have been identified, but further research is needed Acknowledgement: This article is a summary of “A Systematic Review of Self-Management Interventions for Children and Adolescents With Inflammatory Bowel Disease” r...